E@ECIPE
4 Million Tonnes Additional CO2 due to Proposed EU #Cabotage Laws in #MobilityPackagehttps://t.co/6T9Mc4h0dU… https://t.co/EyeMuKCnNSRT Oscar Guinea @osguinea: We have a new @ECIPE blog for your lunch break. @IacopoMonterosa @P_Lamprecht A short thread to whet your appetit… https://t.co/3LeZWwsQNl📌 New Blog: #Trade in Time of Corona: what’s next for the #EU? ➡️ https://t.co/FbQnALydd3 @IacopoMonterosahttps://t.co/70PijKXlJaRT Hosuk Lee-Makiyama @leemakiyama: Commenting in @japantimes and other @kyodo_english syndicated publications on the prospects of UK/Japan trade negot… https://t.co/bvFh3xzCU4📌 "Debt relief is a hard sell. It would be remarkable if the EU countries would forgive debts in Africa, while refu… https://t.co/4ih1HkXmfk
  • FOLLOW ECIPE
x
Browse

Published

The European Commission’s pharmaceutical innovation incentives review is at risk of serious overreach

By: Guest Author 

Subjects: European Union Healthcare